SYNERGY CHC CORP (SNYR)
NASDAQHealth CareMedical - DistributionSnapshot 2026-10-21
$0.01+5.15%
Close 2026-09-28 · 1-day change
NASDAQHealth CareMedical - DistributionSnapshot 2026-10-21
Research Workspace
Put SNYR beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Primary pillar under pressure — Address financial and regulatory compliance issues: Nasdaq delisting notice received vs Q4 2026 compliance target.
View ThesisMiddle-of-the-pack management execution.
View ManagementThis stock is highly volatile — it swings about 4% on a typical day and fell roughly 99% in its worst 12-month stretch.
View RiskSNYR’s case rests on steady financial performance, despite unprofitable results and high risk. The latest release is absent, so revenue growth and a beat cannot be confirmed. No valuation multiples or priced-in expectations are available to define the market’s view. A 59% next-quarter miss probability threatens the case. Nasdaq’s delisting notice puts its Q4 2026 compliance target under pressure. No valuation read is available; the thesis is on watch. This read is provisional.
Trailing returns as of 2026-09-28. SNYR is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 2 analysts currently covering SNYR (as of Sep 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare SNYR with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| SNYR Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 0 valuation methods, at three horizons. As of 2026-10-21. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Health Care (broad) — fair value, gap to price, and forward P/E.
Compare the value case
Put SNYR next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Default notice indicates financial distress.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-28. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
